Expression of a type B RIFIN in Plasmodium falciparum merozoites and gametes
- Steven B Mwakalinga†1,
- Christian W Wang†1Email author,
- Dominique C Bengtsson1,
- Louise Turner1,
- Bismarck Dinko2,
- John P Lusingu3,
- David E Arnot1, 4,
- Colin J Sutherland2,
- Thor G Theander1 and
- Thomas Lavstsen1
© Mwakalinga et al.; licensee BioMed Central Ltd. 2012
Received: 31 July 2012
Accepted: 19 December 2012
Published: 21 December 2012
The ability of Plasmodium falciparum to undergo antigenic variation, by switching expression among protein variants encoded by multigene families, such as var, rif and stevor, is key to the survival of this parasite in the human host. The RIFIN protein family can be divided into A and B types based on the presence or absence of a 25 amino acid motif in the semi-conserved domain. A particular type B RIFIN, PF13_0006, has previously been shown to be strongly transcribed in the asexual and sexual stages of P. falciparum in vitro.
Antibodies to recombinant PF13_0006 RIFIN were used in immunofluorescence and confocal imaging of 3D7 parasites throughout the asexual reproduction and sexual development to examine the expression of PF13_0006. Furthermore, reactivity to recombinant PF13_0006 was measured in plasma samples collected from individuals from both East and West African endemic areas.
The PF13_0006 RIFIN variant appeared expressed by both released merozoites and gametes after emergence. 7.4% and 12.1% of individuals from East and West African endemic areas, respectively, carry plasma antibodies that recognize recombinant PF13_0006, where the antibody responses were more common among older children.
The stage specificity of PF13_0006 suggests that the diversity of RIFIN variants has evolved to provide multiple specialized functions in different stages of the parasite life cycle. These data also suggest that RIFIN variants antigenically similar to PF13_0006 occur in African parasite populations.
The life cycle of the Plasmodium falciparum malaria parasite involves asexual and sexual phases. To maintain a persistent infection in the human host for successful transmission to mosquitoes, parasites express various polymorphic proteins that help evade human antibody responses and facilitate invasion of host cells. During asexual multiplication in the blood, parasites invade and multiply inside erythrocytes, apart from short periods as extracellular merozoites, which are released at erythrocyte rupture and then quickly re-invade fresh host cells. Polymorphic proteins like merozoite surface proteins 1 (MSP-1) and apical membrane antigen 1 (AMA-1)[1, 2] are expressed on the merozoite surface and are known to play specific roles in erythrocyte invasion. The STEVOR family of variant antigens are also known to be expressed on the merozoite surface and to be associated with the plasma membrane of mature gametocyte-infected erythrocytes. The locations of the related, highly diverse RIFIN antigen family members are less well understood, but they have been reported to be present inside the merozoite. Each parasite carries approximately 150–200 rif and 30–35 stevor gene copies per genome, and it remains a possibility that their abundance and diversity also contribute to immune evasion by merozoites during their brief extra-cellular phase.
While it is uncertain whether rif genes are expressed in a ‘relaxed’ or strictly mutually exclusive manner, multiple RIFIN variants have been reported in bulk cultures of parasites grown in vitro[6, 7]. Rifin variants can be divided into A- and B-types based on the presence or absence of a 25 amino acid motif in the semi-conserved domain and sub-structuring of RIFIIN protein sequence reflect functional divergence with A- and B-types serving different roles in distinct parasite stages. During intraerythrocytic multiplication B-type RIFIIN were reported to be retained inside the parasites while A type RIFIN were expressed on the infected erythrocyte surface, potentially contributing to the antigenic variation capacity of the parasite.
Plasmodium falciparum pathology is profoundly influenced by the sequestration of infected erythrocytes to microvascular endothelium in various tissues. This involves interactions between parasite adhesins and several human endothelial receptors including CD36, ICAM1 and the glycosaminoglycan, CSA[9, 10]. During sexual development in vivo, mature gametocytes of P. falciparum (Stage V) do not appear in the peripheral blood circulation until 7–15 days after the initial wave of blood stream infection appears. This is due to the sequestration of immature gametocyte forms, which develop in various host tissues including the bone marrow and spleen[12, 13]. Although superficially analogous to the sequestration of mature asexual parasite stages, the details of interactions between developmental stages of gametocytes and host tissues are poorly understood, and if cytoadherence is involved, the host receptors responsible remain unidentified. Candidate receptors for adhesion of early gametocytes (Stage I, II) include CD36 and for stage III to IV include ICAM-1, CD49c, CD164 and CD166. Candidate gametocyte-expressed parasite ligands may include variants of the multigene families var, rif and stevor. Of these, cytoadhesive properties have only been demonstrated for PfEMP1, which has been linked to cytoadhesion of gametocyte stages I to IIA. In the later stages III to IV, PfEMP1 was observed to be retained inside parasite cytoplasm; possibly indicating that PfEMP1 may not be involved in gametocyte cytoadherence after stage IIB. However, more recent transcriptional data suggest that certain group C var genes are selectively transcribed during gametocytogenesis in vitro, suggesting a role for this subset of PfEMP1 in gametocytes, gametes or later parasite stages in the mosquito. Type A RIFIN has been found on the surface of developing gametocytes and type B Rifin expressed but retained inside the cell at all gametocyte stages. STEVOR proteins are localized near the developing gametocyte surface membrane, but surface exposure and any direct role in adhesion to host tissues, remains to be confirmed. However, recently, Tibùrcio and colleagues showed that cell rigidity of immature gametocyte-infected erythrocytes was associated with the expression of STEVOR proteins, potentially contributing to the sequestration of these stages by mechanical retention rather than adhesion.
Although antisera have been developed which can distinguish type A from type B RIFIN sub-groups, variant-specific RIFIN antibodies have not previously been described. In previous studies[18, 21] global transcription analysis of all rif genes in sexual and asexual development of the 3D7 parasite line revealed a unique expression pattern of the type B rif gene PF13_0006. This gene was up-regulated in late stage schizonts, developing gametocytes and in sporozoites. To test the hypothesis that this RIFIN variant has a distinctive role in parasite development, antibodies to the protein encoded by PF13_0006 were developed and the expression was followed throughout parasite development in vitro. Evidence is presented suggesting that this specific type B RIFIN variant is expressed on the surface of free merozoites, internally in developing gametocytes and on the surface of gametes at the point of emerging from activated, mature stage V gametocytes.
Sequences, alignments and distance tree analysis
The variable domain, V2, of 3D7, HB3 and DD2 RIFIN amino acid sequences were aligned, viewed and Neighbour Joining distance trees built as previously described. To these earlier described sequences 107 IT/FCR3 RIFIN sequences retrieved by text search in http://www.plasmoDB.org were included in the alignments giving a total of 481 RIFIN amino acid sequences. Sequence logos were generated using WebLogo (version 2.8).
Parasite culture and synchronization
Asexual blood stages of P. falciparum parasites of the line 3D7 were cultured and magnet-purified based on standard protocols, with modifications as previously described[17, 25–27]. Gametocytes of P. falciparum clone 3D7 were cultivated using previously established methods[28–31]. Culture media was changed on a daily basis and parasites were monitored by visualizing of Giemsa-stained smears under the light microscope. Parasites at various develo7pmental stages of gametocytogenesis were harvested and purified using MACS as described previously[32, 33]. To activate mature stage V gametocytes to differentiate into gametes, parasites were incubated for 10 minutes at room temperature with five times pellet volume of 100 μM Xanthurenic acid (Sigma-Aldrich) in cold RPMI. Parasites were then harvested and observed microscopically during rounding up and exflagellation.
Recombinant protein and antibody production
Recombinant proteins were produced in the baculovirus expression system as described previously. Primer pairs were designed to amplify the variable domain of PF13_0006 and PFD0070c rif genes from genomic DNA of the 3D7 parasite line. PCR products were cloned into baculovirus expression vector pAcG2T (BD Bioscience) containing an N-terminal GST tag, and expressed as previously described. Recombinant proteins were harvested and purified on gluthatione sepharose columns. Polyclonal antisera were generated in rabbits as previously described. Experiments including immunizations and bleeding of animals were approved by The Danish Animal Procedures Committee (“Dyreforsoegstilsynet”) as described in permit no. 2008/561-1498 and according to the guidelines described in act no. LBK 1306 (23/11/2007) and BEK 1273 (12/12/2005). The antiserum was tested positive in ELISA for reactivity against the immunizing antigen and the antiserum was depleted for antibodies reacting with erythrocyte antigens by mixing equal amounts of antiserum with human O+ erythrocytes and incubating 24 h at 4°C. The depleted antiserum was IgG purified on protein G sepharose columns and dialyzed overnight in PBS. To demonstrate the specificity of the anti-PF13_0006 IgG, IT/FCR3 parasites, which do not contain a rif with high sequence similarity to PF13_0006 in their genome, were used in immunofluorescence and western blot analyses (Additional file 1 and Additional file 2, respectively). As a negative control for the anti-PF13_0006 IgG preparation, a rabbit with a recombinant protein representing another RIFIN (PFD0070c) was immunized. The resulting anti-PFD0070c antibody did not react with parasite extracts, either because the protein was not expressed by the cultured parasites or because the antibodies did not react with the native protein. However, these antibodies did show ELISA reactivity against the recombinant protein used for the immunization and was hereafter termed as control IgG.
Primer design and quantitative PCR
RNA extraction and quantitative reverse-transcriptase PCR were carried out as previously described[17, 21]. Quantitative primers for rif gene PF13_0006, universal rifA2 and for amplification of the endogenous comparator genes seryl tRNA synthetase and fructose-bisphosphate aldolase, have been described previously[22, 37]. Primers were designed for rif subgroups RifA1 and RifA3: RifA1 F 5 ACAAAATTTGGGAGGGGTTG 3 and RifA1 R 5 TGCCTTAAGACCTGCATCTG 3; and RifA3 F 5 AGCAGGACATTTGGCRGGTAC 3 and RifA3 R 5 ACKAGGTGTACATRACGTGR 3.
IFA on fixed smears
Immunofluorescent antibody assays were performed on gametocytes and asexual stages on fixed smears using standard methods. Primary antibodies used were rabbit IgG raised to PF13_0006 and control IgG, monoclonal antibody 1H12 specific for Pfg27/25 and monoclonal antibody against Pfs230. Visualization was with the 60X oil immersion lens on a Nikon TE 2000-E confocal microscope.
For the analysis of gametes, fixation was carried out without permeabilizing the parasites with Triton X-100. An antibody recognizing human glycophorin A (BD Bioscience) was used to visualize the erythrocyte membrane.
Double immunofluorescent detection of PF13_0006 and MSP-119 in live schizonts
Synchronized live schizonts were MACS purified in warmed 2% BSA/FCS and permeabilized at 30°C with 500 μl pneumolysin at a 300 μg/ml concentration. The perforated schizonts were washed twice with 1% PBS/BSA resuspended in 92 μl 1% PBS/BSA, 4 μl PF13_0006 or 4 μl control IgG, 1 μl MSP-119 antibodies and 3 μl DAPI at 5 μg/ml. The parasites were incubated for 45 minutes at 4°C, washed three times with 1% PBS/BSA and then incubated for 30 minutes at 4°C with 100 μl Alexa 488 anti-rabbit/alexa 568 anti-mouse IgG (Invitrogen) at 1/2000 and 3 μl DAPI (Sigma) at 5 μg/ml. After thorough washing, schizonts were vizualized on live wet preparation with laser scanning confocal microscopy performed using a Nikon TE 2000-E confocal microscope with 60X oil immersion objective lens (DCI) as previously described.
Double immunofluorescent detection of PF13_0006 and MSP-119 on live merozoites
Merozoites were collected according to a previous method with some modifications. Briefly, Concanavalin (5 mg/ml) in sterile distilled water was added to cover the bottom of a sterile petri plate (falcon) and incubated at 37°C for 30 minutes. The plate was then washed with distilled water. A synchronized parasite culture at schizont stage was added to the plate and incubated for 30 minutes. The plate was carefully washed with RPMI media and new media was added. The parasites were incubated for two hours at 37°C. The supernatant containing the merozoites was collected, centrifuged at 2,000 rpm for five minutes, washed three times in 1% PBS/BSA and then stained as above. Live schizonts and merozoites of the parasite line IT/FCR3 were used as controls and were stained as above with following modification: no double staining was done and only Alexa 488 anti-rabbit IgG (Invitrogen) was used. The colour of the MSP-119 staining was converted using Nikon EZ-C1 Freeviewer Software from green to red for easy comparison with the staining of the 3D7 parasite line.
Protein extracts from MACS-purified mature stage gametocytes from day 15 of gametocytogenesis were further concentrated using a modified two detergent protocol comprising two cold 1% Triton X-100 extractions followed by 2% sodium dodecyl sulphate (SDS) extraction. For western blotting, protein extracts were mixed with loading dye and separated by SDS-PAGE before being transferred to nitrocellulose membrane for two hours at 30 V. Proteins of interest were visualized by sequential incubation with primary and secondary antibodies followed by chemiluminescent detection.
Plasma samples were obtained during village surveys as part of on-going monitoring of malaria endemicity on North Eastern Tanzania. For this study, 1,303 samples from children and adults aged six months to 60 years were thawed and analyzed for presence of IgG reacting with recombinant PF13_0006. Plasma samples from children participating in malaria drug efficacy trials in The Gambia were also tested. The antibody reactivity was measured in a bead based Luminex assay as previously described, using beads coated with the PF13_0006 and control beads coated with GST. For each donor the reactivity with GST coated beads was subtracted from the reactivity measured with beads coated with PF13_0006. Cut-off was based on the mean reactivity +2 SD of European donors never exposed to malaria. Informed consent forms were signed by parent or legal guardians of all subjects and the trials in Tanzania and in The Gambia were reviewed and approved by the Medical Research Coordinating Committee, Tanzania (NIMR/HQ/R.8a/Vol.IX/559), and by the Medical Research Council/Gambian Government Joint Ethical Committee, respectively.
PF13_0006 RIFIN is expressed in the schizonts but not in the ring stages of asexual parasites
PF13_0006 RIFIN expression of live merozoites
PF13_0006 RIFIN is expressed throughout gametocyte development
Anti-PF13_0006 IgG detects protein of similar size to PF13_0006 Rifin in western blots of mature stage V gametocyte protein extracts
PF13_0006 RIFIN expression of gametes
Sequence analysis of B1 RIFINs
Previous grouping of the variable domain, V2, of RIFINs has identified group A, B and subgroups B1 and B2 RIFINs. PF13_0006 is one of 37 RIFINs grouped as a B1 RIFIN in parasite clones 3D7, HB3, DD2, and IT/FCR3. To further identify sequence traits characteristic for the B1 RIFINs, the V2 of 481 3D7, IT/FCR3, HB3 and DD2 RIFIN sequences was split in three, V2-A, V2-B and V2-C, based on two central cysteines present in most sequences (~88%) (Additional file 6A). The three V2-subdomains were re-aligned separately and Neighbour Joining distance trees were built showing the V2-C domain being the best to cluster the sub-group B1 RIFINs (Additional file 6B). A sequence logo was generated based on the V2-C domain of 37 B1 RIFINs showing that the C-terminal part of the V2-C is particularly conserved and unique for the B1 RIFINs (Additional file 6C). The average sequence identity of this part is 62%.
Reactivity against PF13_0006 in plasma from malaria endemic areas
Anti-PF13_0006 IgG antibodies among 1303 individuals living in North Eastern Tanzania
Odds ratio and 95% confidence interval
Age group (years)
0-2 (N = 172)
1 (reference group)
2-4 (N = 370)
4-7 (N = 492)
7-11 (N = 309)
12-60 (N = 180)
Year of sampling
Kwamasimba (Low transmission village)
Mkokola (High transmission village)
Furthermore, plasma samples from 182 Gambian children participating in malaria drug efficacy trials during 2001 and 2002 were also evaluated for the presence of antibodies recognizing recombinant PF13_0006. The seropositivity rate was 12.1% (Additional file 7B).
The P. falciparum parasite uses clonal antigenic variation to evade host antibody immune responses and permit the establishment of the fairly long-lasting infections that individual clones require for their transmission back to the mosquito vector. It is difficult to know what the average clonal transit time through the human host is, but it is unlikely to be shorter than three weeks and could be significantly longer. While the important role of PfEMP1 in antigenic variation during the intra-erythrocytic multiplication stages is well established, antigenic variation during merozoite, gametocyte and gamete stages has not been formally demonstrated in P. falciparum, although a role for RIFIN and STEVOR proteins remains plausible.
A-type Rifins are found associated with the surface of infected erythrocytes and gametocytes and thus appear to follow the expression pattern of PfEMP1, whereas surface exposure of STEVOR so far has only been confirmed on merozoites. The data presented here show that a specific type B RIFIN variant (PF13_0006) is expressed by free, live merozoites and gametes (activated gametocytes). Transcript analysis presented here and previously[21, 22] unambiguously show that this RIFIN is upregulated in early ring, schizonts and late stage gametocytes. To investigate PF13_0006 protein expression, rabbit antibodies to the variable region of this protein were generated. These antibodies stained the surface of 3D7 merozoites and gametes, but not the surface of intact 3D7 gametocytes or FCR3 merozoites. Also the antibodies only detected correctly sized protein in western blots of 3D7 schizonts and gametocytes extracts and not of 3D7 rings or FCR3 schizonts. Thus, although the antibodies appear to un-specifically target a number of other proteins in the western blots, collectively the data support the expression of PF13_0006 protein on the surface of merozoites and gametes. The expression of PF13_0006 inside the parasite during schizont and gametocyte stages is in agreement with previous reports using antibodies with specificity for B-type RIFINs[5, 18]. There is as yet no evidence that expression of RIFIN variants is mutually exclusive[5, 36]. Transcript analyses published earlier[21, 22] indicate that transcripts of other B1 RIFINs, in particular PFI0025c, encoding the unique sequence motif identified in this study are present in merozoites and gametes at the same time as PF13_0006. High transcript levels of PF13_0006 were also detected in early rings but no protein was detected which could reflect a spill-over of late stages in the synchronization. It should also be noted that the method for detecting transcripts is much more sensitive than the methods used to detect protein.
A proportion of malaria exposed individuals from both East and West Africa had acquired plasma antibodies recognizing recombinant PF13_0006. The seropositive rate was slightly higher among the Gambian children, but this probably reflected that these children participated in a treatment trail and therefore had a recent exposure. The data suggest that RIFIN variants antigenically similar to the variable domain of PF13_0006 occur in the African parasite populations possibly in particular the unique sequence motif of the B1 RIFINs. These antibody responses were more common among older children than in adults. A similar decline in anti-PfEMP1 seropositivity was reported previously and probably reflect that the antibody levels to these polymorphic proteins are short lived and that adults who have acquired partial immunity have less parasite exposure than the children. The prevalence of antibodies did not vary consistently with the level of transmission and was higher in the Tanzanian samples collected in 2008 than in the previous years, despite a general decline in transmission in the area. This could reflect temporal shifts in the relative abundance of parasites carrying RIFIN variants closely related to PF13_0006, as similar fluctuations related to time and geographical location have been observed for antibody recognition of different PfEMP1 variants.
Confocal imaging of live, non-fixed, non-permeabilized free merozoites is challenging due to the small size and motility of these stages. However, present data does indicate that PF13_0006 is co-localized with MSP1 on the merozoite surface. This would place RIFIN along with the other variant surface antigens such as SURFINs and STEVOR which recently have been shown to be expressed on the surface of free merozoites. These studies of diverse multigene families, taken together, suggest that the antigens they encode play a role in evading the immune response against merozoites. However, as group B RIFIN only comprise ~25% (40 genes in the 3D7 genome) of the family, and the B1 sub-group around half of this proportion, indicating that there is scope for other members of the family to play different roles in the parasite life cycle. It is thus tempting to speculate that the B or B1 type RIFINs have become functionally specialized for a particular role in relation to merozoite egress or erythrocyte invasion.
Similarly, the PF13_0006 B1 RIFIN may serve a particular role either within the developing gametocyte, or in emergent gametes. Whether PF13_0006 serves a role in fertilization, e.g. locating and/or binding to a “partner” cell of opposite mating type, remains to be investigated. However, it is important to note that 3D7 sporozoites have also been found to specifically transcribe the PF13_0006 rif gene. Extrapolating observations from single parasite isolates is unsound and there is a need to investigate rif expression on other genetic backgrounds, but the finding that PF13_0006 appear to be expressed in all free-living stages of 3D7 highlights the need for functional studies of this RIFIN in extracellular forms of the parasite.
The rif gene family is part of the pir (Plasmodium interspersed repeats) gene super-family of six variant multigene families found in Plasmodium vivax (vir), Plasmodium ovale (oir), Plasmodium knowlesi (kir) and in three rodent malarias (Plasmodium chabaudi, cir; Plasmodium berghei, bir; Plasmodium yoelii, yir). Sequence analysis of these gene families, as for rif genes, show compartmentalization into sub-groups/types indicative of specialized functions rather than sequence variation for antigenic variation alone. This function may be common to all Plasmodium species which share life cycle, the common challenges of host immunity, and the need for invasion and rupture of host cells. The variable domain of PF13_0006, the domain to which the antibody was raised, seems to be semi-conserved in the C-terminal part for the B1 subtype RIFINs. This part of the protein may serve a common function for the subtype and it may be possible to generate antibodies targeting B1 RIFINs expressed by different parasite clones.
In conclusion, the PF13_0006 B1 type RIFIN seem expressed on the surface of extra-cellular merozoites and gametes, which suggest some specific, common function for the B1 type RIFIN in P. falciparum’s extracellular forms in both the human host and mosquito vector. Further studies may demonstrate the functionality of this antigen family.
We sincerely thank the children participating in this study and parents or guardians including teams which conducted studies in Tanzania and The Gambia. We thank Richard Carter for providing 1H12 and Pfs230 antibodies, JS McBride for the gift of MSP-119, and Dr. Graeme Cowan for the gift of pneumolysin, University of Edinburgh, United Kingdom. SBM was supported during this work by DANIDA, and CWW was supported by The Danish Medical Research Council (grant reference number 271-08-0540) and Augustinus Fonden. CJS is supported by the UK Health Protection Agency. DB and DEA were supported by a Niels Bohr Foundation visiting professorship to DEA, awarded by Danmarks Grundforskningsfonds. LT received support from University of Copenhagen Program of Excellence. TL was supported by the Lundbeck Foundation and The Danish Medical Research Council.
- Goel VK, Li X, Chen H, Liu SC, Chishti AH, Oh SS: Band 3 is a host receptor binding merozoite surface protein 1 during Plasmodium falciparum invasion of erythrocytes. Proc Natl Acad Sci USA. 2003, 100: 5164-5169. 10.1073/pnas.0834959100.PubMed CentralView ArticlePubMed
- Mitchell GH, Thomas AW, Margos G, Dluzewski AR, Bannister LH: Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect Immun. 2004, 72: 154-158. 10.1128/IAI.72.1.154-158.2004.PubMed CentralView ArticlePubMed
- Khattab A, Meri S: Exposure of the Plasmodium falciparum clonally variant STEVOR proteins on the merozoite surface. Malar J. 2011, 10: 58-10.1186/1475-2875-10-58.PubMed CentralView ArticlePubMed
- McRobert L, Preiser P, Sharp S, Jarra W, Kaviratne M, Taylor MC, Reina L, Sutherland CJ: Distinct trafficking and localization of STEVOR proteins in three stages of the Plasmodium falciparum life cycle. Infect Immun. 2004, 72: 6597-6602. 10.1128/IAI.72.11.6597-6602.2004.PubMed CentralView ArticlePubMed
- Petter M, Haeggström M, Khattab A, Fernandez V, Klinkert MQ, Wahlgren M: Variant proteins of the Plasmodium falciparum Rifin family show distinct subcellular localization and developmental expression patterns. Mol Biochem Parasitol. 2007, 156: 51-61. 10.1016/j.molbiopara.2007.07.011.View ArticlePubMed
- Fernandez V, Hommel M, Chen Q, Hagblom P, Wahlgren M: Small clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune system responses. J Exp Med. 1999, 190: 1393-1404. 10.1084/jem.190.10.1393.PubMed CentralView ArticlePubMed
- Kyes SA, Rowe JA, Kriek N, Newbold CI: Rifin: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proc Natl Acad Sci USA. 1999, 96: 9333-9338. 10.1073/pnas.96.16.9333.PubMed CentralView ArticlePubMed
- Joannin N, Abhiman S, Sonnhammer EL, Wahlgren M: Sub-grouping and sub-functionalization of the Rifin multi-copy protein family. BMC Genomics. 2008, 9: 19-10.1186/1471-2164-9-19.PubMed CentralView ArticlePubMed
- Baruch DI, Gormely JA, Ma C, Howard RJ, Pasloske BL: Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci USA. 1996, 93: 3497-3502. 10.1073/pnas.93.8.3497.PubMed CentralView ArticlePubMed
- Fried M, Duffy P: Adherence of Plasmodium falciparum to chondroitin sulfate A in human placenta. Science. 1996, 272: 1502-1504. 10.1126/science.272.5267.1502.View ArticlePubMed
- Eichner M, Diebner HH, Molineaux L, Collins WE, Jeffery GM, Dietz K: Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg. 2001, 95: 497-501. 10.1016/S0035-9203(01)90016-1.View ArticlePubMed
- Thomson JG, Robertson A: The structure and development of Plasmodium falciparum gametocytes in the internal organs and peripheral circulation. Trans R Soc Trop Med Hyg. 1935, 29: 31-40. 10.1016/S0035-9203(35)90015-3.View Article
- Smalley ME, Abdalla S, Brown J: The distribution of Plasmodium falciparum in the peripheral blood and bone marrow of Gambian children. Trans R Soc Trop Med Hyg. 1980, 75: 103-105.View Article
- Day KP, Hayward RE, Smith D, Culvenor JG: CD36-dependent adhesion and knob expression of the transmission stages of Plasmodium falciparum is stage-specific. Mol Biochem Parasitol. 1998, 93: 167-177. 10.1016/S0166-6851(98)00040-1.View ArticlePubMed
- Rogers NJ, Hall BS, Obiero J, Targett GAT, Sutherland CJ: A Model for sequestration of the transmission stages of Plasmodium falciparum: Adhesion of gametocytes-infected erythrocytes to human bone marrow cells. Infect Immun. 2000, 68: 3455-3462. 10.1128/IAI.68.6.3455-3462.2000.PubMed CentralView ArticlePubMed
- Hayward RE, Tiwari B, Piper KP, Baruch D, Day KP: Virulence and transmission success of the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci USA. 1999, 96: 4563-4568. 10.1073/pnas.96.8.4563.PubMed CentralView ArticlePubMed
- Sharp S, Lavstsen T, Fivelman QL, Saeed M, McRobert L, Templeton TJ, Jensen AT, Baker DA, Theander TG, Sutherland CJ: Programmed Transcription of the var gene family, but not of stevor, in Plasmodium falciparum gametocytes. Eukaryot Cell. 2006, 5: 1206-1214. 10.1128/EC.00029-06.PubMed CentralView ArticlePubMed
- Petter M, Bonow I, Klinkert MQ: Diverse expression patterns of subgroups of the rif multigene family during Plasmodium falciparum gametocytogenesis. PLoS One. 2008, 3: e3779-10.1371/journal.pone.0003779.PubMed CentralView ArticlePubMed
- Tibùrcio M, Niang M, Deplaine G, Perrot S, Bischoff E, Ndour PA, Silvestrini F, Khattab A, Milon G, David PH, Hardeman M, Vernick KD, Sauerwein RW, Preiser PR, Mercereau-Puijalon O, Buffet P, Alano P, Lavazec C: A switch in infected erythrocyte deformability at the maturation and blood circulation of Plasmodium falciparum transmission stages. Blood. 2012, 119: e172-e180. 10.1182/blood-2012-03-414557.PubMed CentralView ArticlePubMed
- Silvestrini F, Tibùrcio M, Bertuccini L, Alano P: Differential adhesive properties of sequestered asexual and sexual stages of Plasmodium falciparum on human endothelial cells are tissue independent. PLoS One. 2012, 7: e31567-10.1371/journal.pone.0031567.PubMed CentralView ArticlePubMed
- Wang CW, Mwakalinga SB, Sutherland CJ, Schwank S, Sharp S, Hermsen CC, Sauerwein RW, Theander TG, Lavstsen T: Identification of a major rif transcription common to gametocytes and sporozoites of Plasmodium falciparum. Malar J. 2010, 9: 147-10.1186/1475-2875-9-147.PubMed CentralView ArticlePubMed
- Wang CW, Magistrado PA, Nielsen MA, Theander TG, Lavstsen T: Preferential transcription of conserved rif genes in two phenotypically distinct Plasmodium falciparum parasite lines. Int J Parasitol. 2009, 39: 655-664. 10.1016/j.ijpara.2008.11.014.View ArticlePubMed
- Bahl A, Brunk B, Crabtree J, Fraunholz MJ, Gajria B, Grant GR, Ginsburg H, Gupta D, Kissinger JC, Labo P, Li L, Mailman MD, Milgram AJ, Pearson DS, Roos DS, Schug J, Stoeckert CJ, Whetzel P: PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res. 2003, 31: 212-215. 10.1093/nar/gkg081.PubMed CentralView ArticlePubMed
- Crooks GE, Hon G, Chandonia JM, Brenner SE: WebLogo: a sequence logo generator. Genome Res. 2004, 14: 1188-1190. 10.1101/gr.849004.PubMed CentralView ArticlePubMed
- Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193: 673-675. 10.1126/science.781840.View ArticlePubMed
- Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979, 65: 418-420. 10.2307/3280287.View ArticlePubMed
- Paul F, Roath S, Melville D, Warhurst DC, Osisanya JO: Separation of malaria-infected erythrocytes from whole blood: use of a selective high-gradient magnetic separation technique. Lancet. 1981, 2: 70-71.View ArticlePubMed
- Ponnudurai T, Lensen AH, Leeuwenberg AD, Meuwissen JH: Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures. Trans R Soc Trop Med Hyg. 1982, 76: 812-818. 10.1016/0035-9203(82)90116-X.View ArticlePubMed
- Ponnudurai T, Lensen AH, Meis JF, Meuwissen JH: Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology. 1986, 93: 263-274. 10.1017/S003118200005143X.View ArticlePubMed
- Gupta SK, Schulman S, Vanderberg JP: Stage-dependent toxicity of N-acetyl-glucosamine to Plasmodium falciparum. J Protozool. 1985, 32: 91-95.View ArticlePubMed
- Fivelman QL, McRobert L, Sharp S, Taylor CJ, Saeed M, Swales CA, Sutherland CJ, Baker DA: Improved synchronous production of Plasmodium falciparum gametocytes in vitro. Mol Biochem Parasitol. 2007, 154: 119-123. 10.1016/j.molbiopara.2007.04.008.View ArticlePubMed
- Staalsoe T, Giha HA, Dodoo D, Theander TG, Hviid L: Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. Cytometry. 1999, 35: 329-336. 10.1002/(SICI)1097-0320(19990401)35:4<329::AID-CYTO5>3.0.CO;2-Y.View ArticlePubMed
- Saeed M, Roeffen W, Alexander N, Drakeley CJ, Targett GA, Sutherland CJ: Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte. PLoS One. 2008, 3: e2280-10.1371/journal.pone.0002280.PubMed CentralView ArticlePubMed
- Jensen AT, Magistrado P, Sharp S, Joergensen L, Lavstsen T, Chiucchiuini A, Salanti A, Vestergaard LS, Lusingu JP, Hermsen R, Sauerwein R, Christensen J, Nielsen MA, Hviid L, Sutherland CJ, Staalsoe T, Theander TG: Plasmodium falciparum associated with severe childhood malaria preferentially express PfEMP1 encoded by group A var genes. J Exp Med. 2004, 199: 1179-1190. 10.1084/jem.20040274.PubMed CentralView ArticlePubMed
- Turner L, Wang CW, Lavstsen T, Mwakalinga SB, Sauerwein RW, Hermsen CC, Theander TG: Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers. PLoS One. 2011, 6: e29025-10.1371/journal.pone.0029025.PubMed CentralView ArticlePubMed
- Joergensen L, Bengtsson DC, Bengtsson A, Ronander E, Berger SS, Turner L, Dalgaard MB, Cham GK, Victor ME, Lavstsen T, Theander TG, Arnot DE, Jensen AT: Surface co-expression of two different PfEMP1 antigens on single Plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1. PLoS Pathog. 2010, 6: e1001083-10.1371/journal.ppat.1001083.PubMed CentralView ArticlePubMed
- Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP, Arnot DE, Hviid L, Theander TG: Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol. 2003, 49: 179-191. 10.1046/j.1365-2958.2003.03570.x.View ArticlePubMed
- Carter R, Graves PM, Creasey A, Byrne K, Read D, Alano P, Fenton B: Plasmodium falciparum: an abundant stage specific protein expressed during early gametocyte development. Exp Parasitol. 1989, 69: 140-149. 10.1016/0014-4894(89)90182-3.View ArticlePubMed
- Read D, Lensen AH, Begarnie S, Haley S, Raza A, Carter R: Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunol. 1994, 16: 511-519. 10.1111/j.1365-3024.1994.tb00305.x.View ArticlePubMed
- Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, Holder AA, Hviid L, Theander TG, Arnot DE, McBride JS: A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol. 1998, 161: 347-359.PubMed
- Bengtsson DC, Sowa KM, Arnot DE: Dual fluorescence labeling of surface-exposed and internal proteins in erythrocytes infected with the malaria parasite Plasmodium falciparum. Nat Protoc. 2008, 3: 1990-1996. 10.1038/nprot.2008.196.View ArticlePubMed
- Ranford-Cartwright LC, Sinha A, Humphreys GS, Mwangi JM: New synchronization method for Plasmodium falciparum. Malar J. 2010, 9: 170-10.1186/1475-2875-9-170.PubMed CentralView ArticlePubMed
- Mmbando BP, Vestergaard LS, Kitua AY, Lemnge MM, Theander TG, Lusingu JP: A progressive declining in the burden of malaria in north-eastern Tanzania. Malar J. 2010, 9: 216-10.1186/1475-2875-9-216.PubMed CentralView ArticlePubMed
- Cham GK, Kurtis J, Lusingu J, Theander TG, Jensen AT, Turner L: A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma. Malar J. 2008, 7: 108-10.1186/1475-2875-7-108.PubMed CentralView ArticlePubMed
- Kuehn A, Pradel G: The coming out of malaria gametocytes. J Biomed Biotechnol. 2010, 2010: 976827-PubMed CentralView ArticlePubMed
- Cham GK, Turner L, Lusingu J, Vestergaard L, Mmbando BP, Kurtis JD, Jensen AT, Salanti A, Lavstsen T, Theander TG: Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains. J Immunol. 2009, 183: 3356-3363. 10.4049/jimmunol.0901331.View ArticlePubMed
- Bejon P, Turner L, Lavstsen T, Cham G, Olotu A, Drakeley CJ, Lievens M, Vekemans J, Savarese B, Lusingu J, Von Seidlein L, Bull PC, Marsh K, Theander TG: Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites. PLoS One. 2011, 6: e21711-10.1371/journal.pone.0021711.PubMed CentralView ArticlePubMed
- Winter G, Kawai S, Haeggström M, Kaneko O, Von Euler A, Kawazu S, Palm D, Fernandez V, Wahlgreen M: SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes. J Exp Med. 2005, 201: 1853-1863. 10.1084/jem.20041392.PubMed CentralView ArticlePubMed
- Janssen CS, Phillips RS, Turner CM, Barrett MP: Plasmodium interspersed repeats: the major multigene superfamily of malaria parasites. Nucleic Acids Res. 2004, 32: 5712-5720. 10.1093/nar/gkh907.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.